ACCURINS Canadian Trademark Information

On Thursday, October 8, 2015, a canadian trademark registration was filed for ACCURINS by Pfizer Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1749758. The current status of this trademark filing is Registration published. The ACCURINS trademark is filed in the description of Medicinal preparations for the treatment of infectious diseases and for use in oncology, namely, intravenously administered injectable therapeutic delivery agents comprising polymeric nano-particles incorporating therapeutic payloads, which accumulate at the site of diseased and cancerous cells to specifically target these cells for controlled and timely release of the therapeutic payload , Medicinal preparations for the treatment of infectious diseases, namely intestinal infections, gastrointestinal infections, urinary tract infections, nosocomial infections, meningitis, pneumonia, sepsis and staph infections, respiratory infections, eye infections, tissue infections, fungal and parasitic infections and for use in oncology, namely, intravenously administered injectable therapeutic delivery agents comprising polymeric nano-particles incorporating therapeutic payloads, which accumulate at the site of diseased and cancerous cells to specifically target these cells for controlled and timely release of the therapeutic payload. , Medicinal preparations for the treatment of infectious diseases, namely intestinal infections, gastrointestinal infections, urinary tract infections, nosocomial infections, meningitis, pneumonia, sepsis and staph infections, respiratory infections, eye infections, tissue infections, fungal and parasitic infections and for use in oncology, namely, intravenously administered injectable therapeutic delivery agents comprising polymeric nano-particles incorporating therapeutic payloads, which accumulate at the site of diseased and cancerous cells to specifically target these cells for controlled and timely release of the therapeutic payload. , Medicinal preparations for the treatment of infectious diseases, namely intestinal infections, gastrointestinal infections, urinary tract infections, nosocomial infections, meningitis, pneumonia, sepsis and staph infections, respiratory infections, eye infections, tissue infections, fungal and parasitic infections and for use in oncology, namely, intravenously administered injectable therapeutic delivery agents comprising polymeric nano-particles incorporating therapeutic payloads, which accumulate at the site of diseased and cancerous cells to specifically target these cells for controlled and timely release of the therapeutic payload. .